BBI interviewed Drs. Evan Eichler and Danny Miller, as well as postdoctoral fellow Dr. Glennis…
dcorriganMay 9, 2022
IPD scientists report in Nature Biotechnology the design of custom protein-based biosensors that can detect coronavirus-neutralizing…
dcorriganMay 9, 2022
BBI’s Dr. Danny Miller and the UW’s Nanopore Sequencing Core are providing both targeted and…
dcorriganMay 6, 2022
One question inspired Erik Wambre, PhD, to dedicate his career to allergy research. “Why can…
dcorriganMay 6, 2022
Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in…
dcorriganMay 4, 2022
Zymeworks, a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that it has completed…
dcorriganMay 2, 2022
A just-published study provides previously unknown answers about which hospitalized COVID-19 patients are most likely…
dcorriganMay 2, 2022
A group of rare diseases called ciliopathies — polycystic kidney disease notable among them — emerge…
dcorriganApril 29, 2022